FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225753827> ?p ?o ?g. }

• W4225753827 endingPage "403" @default.
• W4225753827 startingPage "392" @default.
• W4225753827 abstract "Papillary renal cell carcinoma (PRCC) is well-recognized as a morphologically and molecularly heterogenous group of kidney tumors with variable clinical behavior. Our goal was to analyze a unique histologic pattern of PRCC we have observed in routine practice to evaluate for potential clinical significance or distinct molecular signature. We identified 42 cases of PRCC showing a morphologically distinct architecture characterized by numerous epithelial-lined cysts containing the papillary tumor (herein called microcysts), which are typically separated by fibrous stroma. Of the initial 42 case test set with microcystic features, 23 (55%) were stage pT3a or higher. Most tumors had strong and diffuse cytoplasmic immunoreactivity for CK7 (93%, 37/40) and AMACR (100%, 40/40). Fumarate hydratase staining was retained in all cases tested (39/39). We performed next-generation sequencing on 15 of these cases with available tissue and identified chromosomal alterations commonly reported in historically type 1 PRCC, notably multiple chromosomal gains, particularly of chromosomes 7 and 17, and MET alterations. However, alterations in pathways associated with more aggressive behavior (including SETD2, CDKN2A, and members of the NRF pathway) were also identified in 6 of 15 cases tested (40%). Given this molecular and immunophenotypic data, we subsequently reviewed an additional group of 60 consecutive pT2b-pT3 PRCCs to allow for comparisons between cases with and without microcysts, to assess for potential associations with other recently described histologic patterns (ie, unfavorable architecture: micropapillary, solid, and hobnail), and to assess interobserver reproducibility for diagnosing architectural patterns and grade. Of the total combined 102 PRCCs, 67 (66%) had microcystic architecture within the intrarenal component but were commonly admixed with other patterns (39% had micropapillary, 31% solid, and 31% hobnail). Twenty-seven cases (26%) had metastatic disease, and 24 of these 27 (89%) had microcystic architecture in the intrarenal tumor. Within the pT3 subset, 21 of 22 cases with metastases (95%) had extrarenal invasion as either individual microcysts in renal sinus fat or aggregates of microcysts bulging beyond the confines of the capsule. Backward elimination and stepwise regression methods to detect features significantly associated with adverse outcome identified solid architecture (hazard ratio [HR]: 6.3; confidence interval [CI]: 2.1-18.8; P=0.001), hobnail architecture (HR: 5.3; CI: 1.7-16.7; P=0.004), and microcystic architecture at the tumor-stromal interface (HR: 4.2; CI: 1.1-16.7; P=0.036) as strongest. Of architectural patterns and grade, the microcystic pattern had a substantial interobserver agreement (κ score=0.795) that was highest among the 6 observers. In summary, PRCCs with microcystic architecture represents a subset of historically type 1 PRCC with a predilection for morphologically distinctive extrarenal involvement and metastatic disease. Microcysts co-vary with other unfavorable architectural patterns also associated with higher risk for aggressive disease (ie, micropapillary, hobnail, and solid), but microcysts were more common and have superior interobserver reproducibility. These findings suggest that microcystic PRCC should be recognized as a potentially aggressive histologic pattern of growth in PRCC." @default.
• W4225753827 created "2022-05-05" @default.
• W4225753827 creator A5002668535 @default.
• W4225753827 creator A5005026596 @default.
• W4225753827 creator A5018130061 @default.
• W4225753827 creator A5026381094 @default.
• W4225753827 creator A5035432552 @default.
• W4225753827 creator A5040995639 @default.
• W4225753827 creator A5041474903 @default.
• W4225753827 creator A5047250521 @default.
• W4225753827 creator A5049749003 @default.
• W4225753827 creator A5070192160 @default.
• W4225753827 date "2021-09-08" @default.
• W4225753827 modified "2023-10-15" @default.
• W4225753827 title "Papillary Renal Cell Carcinoma With Microcystic Architecture Is Strongly Associated With Extrarenal Invasion and Metastatic Disease" @default.
• W4225753827 cites W1556045767 @default.
• W4225753827 cites W1582871569 @default.
• W4225753827 cites W1597363544 @default.
• W4225753827 cites W1743228635 @default.
• W4225753827 cites W1776526479 @default.
• W4225753827 cites W1847884092 @default.
• W4225753827 cites W1968601696 @default.
• W4225753827 cites W1980872806 @default.
• W4225753827 cites W1985111298 @default.
• W4225753827 cites W1989891862 @default.
• W4225753827 cites W1993859430 @default.
• W4225753827 cites W1994766922 @default.
• W4225753827 cites W1994797846 @default.
• W4225753827 cites W2000055543 @default.
• W4225753827 cites W2001056096 @default.
• W4225753827 cites W2009740198 @default.
• W4225753827 cites W2019573100 @default.
• W4225753827 cites W2022168777 @default.
• W4225753827 cites W2033803003 @default.
• W4225753827 cites W2053196138 @default.
• W4225753827 cites W2059521261 @default.
• W4225753827 cites W2062750452 @default.
• W4225753827 cites W2065664525 @default.
• W4225753827 cites W2070124473 @default.
• W4225753827 cites W2080212907 @default.
• W4225753827 cites W2081188316 @default.
• W4225753827 cites W2088492254 @default.
• W4225753827 cites W2090699379 @default.
• W4225753827 cites W2106582614 @default.
• W4225753827 cites W2111867681 @default.
• W4225753827 cites W2112775523 @default.
• W4225753827 cites W2115124576 @default.
• W4225753827 cites W2121296807 @default.
• W4225753827 cites W2123626002 @default.
• W4225753827 cites W2128320141 @default.
• W4225753827 cites W2135269189 @default.
• W4225753827 cites W2136567614 @default.
• W4225753827 cites W2164842424 @default.
• W4225753827 cites W2165507241 @default.
• W4225753827 cites W2165958107 @default.
• W4225753827 cites W2171397743 @default.
• W4225753827 cites W2171763742 @default.
• W4225753827 cites W2314279698 @default.
• W4225753827 cites W2321821822 @default.
• W4225753827 cites W2334823457 @default.
• W4225753827 cites W2342130089 @default.
• W4225753827 cites W2344125398 @default.
• W4225753827 cites W2532493119 @default.
• W4225753827 cites W2579668215 @default.
• W4225753827 cites W2729296789 @default.
• W4225753827 cites W2762272675 @default.
• W4225753827 cites W2767738483 @default.
• W4225753827 cites W2887898741 @default.
• W4225753827 cites W2942938679 @default.
• W4225753827 cites W2957427472 @default.
• W4225753827 cites W2995982924 @default.
• W4225753827 cites W3000637196 @default.
• W4225753827 cites W3009225342 @default.
• W4225753827 cites W3015593149 @default.
• W4225753827 cites W3016510330 @default.
• W4225753827 cites W3029858470 @default.
• W4225753827 cites W3092327219 @default.
• W4225753827 cites W3135698139 @default.
• W4225753827 cites W4234829410 @default.
• W4225753827 cites W4251738294 @default.
• W4225753827 doi "https://doi.org/10.1097/pas.0000000000001802" @default.
• W4225753827 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34881751" @default.
• W4225753827 hasPublicationYear "2021" @default.
• W4225753827 type Work @default.
• W4225753827 citedByCount "6" @default.
• W4225753827 countsByYear W42257538272022 @default.
• W4225753827 countsByYear W42257538272023 @default.
• W4225753827 crossrefType "journal-article" @default.
• W4225753827 hasAuthorship W4225753827A5002668535 @default.
• W4225753827 hasAuthorship W4225753827A5005026596 @default.
• W4225753827 hasAuthorship W4225753827A5018130061 @default.
• W4225753827 hasAuthorship W4225753827A5026381094 @default.
• W4225753827 hasAuthorship W4225753827A5035432552 @default.
• W4225753827 hasAuthorship W4225753827A5040995639 @default.
• W4225753827 hasAuthorship W4225753827A5041474903 @default.
• W4225753827 hasAuthorship W4225753827A5047250521 @default.
• W4225753827 hasAuthorship W4225753827A5049749003 @default.
• W4225753827 hasAuthorship W4225753827A5070192160 @default.

• next